tradingkey.logo

FibroGen Ord Shs

KYNB
9.220USD
-0.280-2.95%
Close 01/09, 16:00ETQuotes delayed by 15 min
--Market Cap
--P/E TTM
You can access the annual and quarterly cash flow statements of FibroGen Ord Shs to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---1.85M
Net income from continuing operations
--200.64M
Operating gains losses
--192.00K
Other non-cash items
--6.58M
Change in working capital
---160.33M
-Change in receivables
--552.00K
-Change in inventory
--1.03M
-Change in prepaid expenses
--3.29M
-Change in other current assets
---1.43M
-Change in other current liabilities
---143.55M
Cash from non-recurring investing activities
Cash from operating activities
---1.85M
Investing cash flow
Net cash from continuing investing activities
--9.00K
Capital expenditures
--9.00K
Net cash flow from disposal of fixed assets
--9.00K
Net cash flow from business transactions
--90.20M
Net cash flow from investment products
---3.04M
Cash from non-current investing activities
Net cash flow from investing activities
--87.16M
Financing cash flow
Cash flow from continuous financing activities
---85.92M
Net cash flow from debt Issuance/repayment
---80.55M
Net cash flow from common stock issuance/repurchase
--0.00
Net cash flow from other financing activities
---5.37M
Net cash from non-recurrent financing activities
Net cash from financing activities
---85.92M
Net cash flow
Beginning cash balance
--119.84M
Current period cash flow changes
---1.87M
Effect of exchange rate changes
---1.26M
Ending cash balance
--117.97M
Free cash flow
---1.86M
Currency unit
USD
Audit opinions
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI